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Abstract
Background: In humans, mutation of ELAC2 is associated with an increased risk of prostate
cancer. ELAC2 has been shown to have tRNase Z activity and is associated with the γ -tubulin
complex.
Results: In this work, we show that the yeast homolog of ELAC2, encoded by TRZ1 (tRNase Z 1),
is involved genetically in RNA processing. The temperature sensitivity of a trz1 mutant can be
rescued by multiple copies of REX2, which encodes a protein with RNA 3' processing activity,
suggesting a role of Trz1p in RNA processing in vivo. Trz1p has two putative nucleotide
triphosphate-binding motifs (P-loop) and a conserved histidine motif. The histidine motif and the
putative nucleotide binding motif at the C-domain are important for Trz1p function because mutant
proteins bearing changes to the critical residues in these motifs are unable to rescue deletion of
TRZ1. The growth defect exhibited by trz1 yeast is not complemented by the heterologous ELAC2,
suggesting that Trz1p may have additional functions in yeast.
Conclusion: Our results provide genetic evidence that prostate cancer susceptibility gene ELAC2
may be involved in RNA processing, especially rRNA processing and mitochondrial function.
Background
With a cumulative incidence by age 75 of 14% among
Caucasian-Americans and 25% among African-Ameri-
cans, prostate cancer has become the most common non-
cutaneous malignancy in the US [1]. Despite its high inci-
dence rate, there is little known about the genetics and eti-
ology of prostate cancer. We recently identified a
candidate prostate cancer susceptibility gene through
linkage analysis and positional cloning [2]. This gene,
ELAC2, is located on chromosome 17p and encodes a
protein of 826 amino acids with tRNase Z activity (tRNA
3' endoribonuclease activity) [3]. ELAC2 belongs to an
incompletely characterized family of proteins that is con-
served among eukaryotes, archaea and bacteria. ELAC2 is
ubiquitously expressed in all tissues with the highest
expression levels found in testes. Elac2p is detected in sev-
eral cancer cell lines and binds the γ -tubulin complex [4].
At present the role that sequence variants in ELAC2 may
play in the genesis of prostate cancer is unclear.
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TRZ1  (tRNase Z 1, YKR079c), the yeast ortholog of
ELAC2, encodes an essential protein of 838 amino acids.
Like ELAC2 and its other eukaryotic orthologs, TRZ1 can
be divided roughly into amino- and carboxy-halves, or
domains, which are structurally homologous [2]. The car-
boxy domain possesses tRNase Z activity; the amino
domain is enzymatically inactive but may modulate the
specificity of carboxy domain. The most strongly con-
served sequence element is the histidine motif, located
near the front of the carboxy domain. In the amino
domain, the structural homolog of the histidine motif is
easily recognizable; however, most of the key zinc coordi-
nating histidines have changed to some other polar
amino acid, which is entirely consistent with the observa-
tion that this domain lacks tRNase Z activity. PROSITE
scans revealed that the vertebrate ELAC2s contain a
sequence element near the center of their amino domain
that matches the nucleotide binding P-loop motif [2].
Although not exactly matching the canonical P-loop
sequence, this sequence element is well conserved in
TRZ1 and its structural homolog is well conserved near
the center of the carboxy domain of all gene family mem-
bers. It has recently been shown that both of the two ELAC
family members (tRNase ZL and tRNase ZS) from the Ani-
mals, Plants, Fungi, Bacteria, and Archaea possess tRNase
Z activity [3,5-9]. The amino acid and enzymatic conser-
vation across ELAC family members suggests strongly that
they all share some basic cellular functions. Since Saccha-
romyces cerevisiae is a well-characterized genetic system, we
initiated a genetic analysis of the functions of the yeast
member of this gene family, TRZ1, in order to better
understand those of ELAC2.
RNA processing, one of the post-transcriptional controls
on gene expression, plays an important role in regulating
cell growth and fate. Pre-mRNA processing is a multi-step
process coupled to transcription through the involvement
of the unique C-terminal domain (CTD) of the large sub-
unit of RNA polymerase II. The processing involves RNA
binding proteins, snRNAs (small nuclear RNAs), endo-
and exo-nucleases, and other specific factors. The function
of these proteins is subject to regulation by different sign-
aling pathways, according to the developmental stage of
the cell [10].
Transfer RNAs (tRNAs) undergo extensive post-transcrip-
tional modifications, including: 5' processing; 3' process-
ing; nucleotide modification; and, in the case of about
20% of yeast tRNA, intron removal in the nucleus before
export to the cytosol. RNase P (ribonuclease P), which
consists of a RNA subunit and nine proteins, is responsi-
ble for 5' tRNA processing (reviewed in [11]). Two pro-
teins, Trz1p [3] and Lhp1p [12], have been shown to be
involved in 3' tRNA maturation in yeast; Trz1p has tRNase
Z activity while Lhp1p stabilizes pre-tRNAs as an RNA
chaperone [3,12]. It is known that there are more than 55
proteins involved in tRNA splicing, modification, degra-
dation and export.
Ribosomal RNAs (rRNAs) are transcribed as large precur-
sors by RNA polymerases I and III in nucleoli [13]. These
RNAs also undergo processing, including 5' and 3' cleav-
ages, removal of introns, and nucleotide modifications
through the action of a series of RNA/protein complexes.
The mature rRNAs complex with about 80 proteins to
form ribosomes. The RNase MRP (ribonuclease MRP)
complex is responsible for the majority of 5' maturation
steps and the exosome complex is responsible for 3' rRNA
maturation. Many of the modifications and splicing
events require small nucleolar RNAs (snoRNAs) and other
specific protein factors. Notably, some proteins are shared
between the tRNA and rRNA maturation complexes
(reviewed in [14]).
In this paper we show that, although Trz1p is required for
growth, yeast are largely insensitive to the absolute level of
its expression. ELAC2 cannot functionally replace Trz1p,
indicating that Trz1p has additional or specific functions.
In the carboxy domain of the protein, the conserved histi-
dine motif and the putative P-loop are important for
Trz1p biological function because mutations of the con-
served residues in these motifs render the protein inactive
in yeast. Through a high copy suppressor screen, we found
that TRZ1 genetically interacts with REX2, suggesting a
role for TRZ1  in RNA processing and mitochondrial
maintenance.
Results
Effect of altered TRZ1 expression on yeast cell growth
We generated three yeast strain types in order to study the
consequences of altered TRZ1 expression in yeast. In the
first (YL09-01 and YL09-02), TRZ1 is expressed from a
Gal1 promoter on a low-copy plasmid in a wild type TRZ1
background. In the second (YL10-04 and YL10-05), the
GAL1 promoter is inserted upstream of TRZ1 between the
translational start site and its endogenous 5'UTR at the
chromosomal locus (no deletion of the endogenous
locus). In the third strain type (YL10-01, YL10-02 and
YL10-03), endogenous TRZ1 is deleted and the gene is
expressed from a GAL1 promoter on a low-copy plasmid.
The latter two strain types were made to investigate the
effect of up- and down- regulation of TRZ1 expression on
growth. The genotypes of all strains used in this study are
listed in Table 1. Also listed in Table 1 is the ρ  +/ρ  - status
of each strain, assayed as the ability of the strain to grow
on media containing only non-fermentable carbon
sources. The significance of the ρ  +/ρ  - status, which repre-
sents the wild type (ρ +) or impaired (ρ -) (petite mutant)
mitochondrial respiratory function, will become clear
below.BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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As shown in Table 2, when TRZ1 is over-expressed in a
wild type background (YL09-01), the yeast doubling time
is 3.7 hours (average of 2 assays, 3.85 hours in one exper-
iment and 3.55 hours in another experiment), not signif-
icantly longer than that of YPH499, the parental yeast
control (3.4 hours; average of 2 assays, 3.11 hours in one
experiment and 3.75 hours in another experiment) or that
of wild type yeast that over-express β -galactosidase (3.0
hours, one assay only). Therefore, over-expression of
TRZ1 in wild type yeast does not significantly slow yeast
growth. Overexpression of FLAG-TRZ1 in YL09-02 was
verified by Western blot with anti-FLAG antibody. As
shown in Figure 1a, FLAG -TRZ1 is rapidly induced in
YL09-02 grown on galactose-containing medium. Nota-
bly, both YL09-01 and YL09-02 are ρ +.
We then investigated the consequence of over-expression
of TRZ1 from the chromosomal locus. In YL10-04 a GAL1
promoter is inserted immediately upstream of the transla-
tional start codon of FLAG-TRZ1. As shown in Figure 1b,
FLAG-TRZ1 is promptly induced after addition of galac-
tose in the YL10-04 strain. Liquid growth assays in a vari-
ety of different media were done to determine the
doubling time of strains expressing varying levels of Trz1p
(Table 2). No growth was observed for YL10-04 and YL10-
05 in galactose medium, respectively, compared to 3.75
hr doubling time forYPH499. However, these GAL1 pro-
moter insertion strains also grew more slowly in non-
inducing medium. The doubling time for YL10-04 and
YL10-05 in glucose medium is 3 and 2 times longer than
that of parental YPH499 cells (Table 2). We experienced
difficulties when trying to isolate Gal1 promoter insertion
strains and found that the isolated strains were petite
mutants; therefore, we decided not to study these strains
further.
We observed the growth characteristics of trz1 strains with
TRZ1 expressed from a GAL1 promoter on a low-copy
plasmid (YL10-01, YL10-02 and YL10-03). As shown in
Table 2, when TRZ1 expression is repressed in glucose
medium, YL10-01 grows marginally slower (doubling
time = 2.95 hours) than YPH500, the isogenic wild type
Table 1: Strains used in this study
YPH499 MATa ura3-52 lys2-801amber ade2-101orchre trp1-∆ 63 his3-∆ 200 leu2-∆ 1 ρ +
YPH500 Same as YPH499 except the mating type is αρ +
YPH501 Same as YPH499 except the mating type is a/αρ +
YL03-47 YPH499 trz1∆ ::hisG (TRZ1 URA3 2 µ) ρ +
YL09-00 YPH499 transformed with Gal1p-β -gal (TRP1, CEN) NA
YL09-01 YPH499 transformed with Gal1p-TRZ1 (TRP1, CEN) ρ +
YL09-02 YPH499 transformed with Gal1p-FLAG•TRZ1 (TRP1, CEN) ρ +
YL10-01 YPH500 trz1∆ ::URA3 (GAL1p-TRZ1 (TRP1, CEN)) ρ -
YL10-02 YPH499 trz1∆ ::hisG (GAL1p-TRZ1 (TRP1, CEN)) ρ -
YL10-03 YPH499 trz1∆ ::hisG (GAL1p-FLAG•TRZ1 (TRP1, CEN)) ρ +
YL10-04 YPH499 trz1::Gal1-FLAG•TRZ1 ρ -
YL10-05 YPH499 trz1::Gal1p-TRZ1 ρ -
YL12-01 YPH499 trz1∆ ::trz1-537 ρ -
YL12-02 YL12-01 transformed with TRZ1 (URA3, CEN) ρ +
YL13-01 YPH499 trz1∆ ::hisG TRZ1 (WT)::LEU2 ρ +
YL13-02 YPH499 trz1∆ ::hisG trz1-537::LEU2 ρ -
YL13-03 YPH499 trz1∆ ::hsiG trz1-538::LEU2 ρ -
Table 2: doubling time (hour)
Strains SC glucose SC galactose
YPH499 2.18 3.11
YL09-00 2.11 2.99
YL09-01 2.20 3.85
YPH499 2.62 3.75
YL10-04 7.70 139
YL10-05 5.64 49.5
YL09-01 2.22 3.55
YPH500 2.27 5.54
YL10-01 2.95 63.0
YPH499 1.90 3.25
YL10-01 2.96 105
YL10-02 2.75 431
YL10-03 1.83 3.17
YL03-47 2.27 3.25
Yeasts were inoculated into 2 mls of SC-raffinose medium and grew 
overnight at 30°C. The overnight culture was then diluted with either 
SC-glucose or SC-galactose to O.D. 600 nm of 0.1 and return to 30°C 
shaking. The O.D. 600 nm reading on these cultures were monitored 
throughout the day until they reached more than 1. The doubling time 
equals to ln (2)/k, where k is the slope of the least-squares linear fit of 
ln (O.D.600 nm) versus time. Spaces between lines in the table 
separate experiments done on different days.BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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yeast (doubling time = 2.27 hours). The same is true for
YL10-02 and YL10-03 with respect to YPH499, their iso-
genic wild type strain. Thus, although TRZ1 is an essential
gene, even low levels of its transcript are sufficient for near
normal growth. When TRZ1  expression is induced in
galactose medium, however, YL10-01 and YL10-02 fail to
grow, while YL10-03 grows at about the same rate as wild
type yeast. This is intriguing, particularly when comparing
YL10-02 and YL10-03, because the strains share the same
genetic background. They differ in two ways: YL10-02 is ρ -
(petite phenotype) while YL10-03 is ρ + (table 1); and
YL10-02 expresses untagged TRZ1  while YL10-03
expresses TRZ1 tagged with a FLAG epitope. The pheno-
typic discrepancy between YL10-02 and YL10-03 is not
likely due to a lack of expression of Trz1p or lack of func-
tional Trz1p in YL10-03, because we could detect
FLAG•TRZ1p in YL10-03 (data not shown) and p414/
Gal1p-FLAG•TRZ1 could functionally complement the
trz1 deletion (Table 4). The difference between the strains
is more likely due to their ρ  status.
We studied these strains further by testing the effect of dif-
ferent carbon sources on their growth. Table 3 summa-
rizes these results. When TRZ1 expression from a Gal1p-
driven TRZ1 plasmid is suppressed on SC-glucose, wild
type yeast (YL09-01) and trz1 yeast (YL10-03) grow at a
rate similar to that of YPH499 at room temperature, 30°C
and 37°C. We could not detect any significant difference
in growth rate among YPH499, YL09-01 and YL10-03 on
sucrose, raffinose or galactose at any temperature tested
(Table 3). This result agrees with the results from liquid
growth assays in that over-expression of TRZ1 in these two
strains (YL09-01 and YL10-03) does not result in any dis-
cernable change in growth rate. When spotted onto glu-
cose media and incubated at room temperature, YL10-01
and YL10-02 grow at a rate equivalent to that of YPH499.
As the incubation temperature is increased, however,
YL10-01 and YL10-02 grow significantly slower than
YPH499. When spotted on sucrose media, these strains
grow slower than YPH499 at all tested temperatures, with
the most significant difference in doubling time occurring
at 37°C. YL10-01 and YL10-02 barely grow on raffinose
and do not grow at all on galactose. As argued above, the
phenotypic discrepancies among the strains is not likely
due to differences in expression of functional TRZ1p.
Instead, the different phenotypes resulting from galac-
tose-induced expression of Trz1p is more likely attributa-
ble to the ρ +/ρ - status of the strains, consistent with the
known inability of ρ - cells to grow on galactose-containing
media [15]. Thus, the ρ - stains (YL10-01, YL10-02, YL10-
04 and YL10-05) show sugar and temperature sensitivity;
the ρ + strains (YL09-01 and YL10-03) do not. In summary,
yeast are largely insensitive to the level of Trz1p, provided
there is some minimal level of the protein; the apparent
sensitivity of some strains to galactose-induced Trz1p
expression is attributable to the non-specific galactose-
sensitivity of ρ - yeast.
ELAC2 does not functionally substitute for TRZ1; motifs 
required for Trz1p function
Since TRZ1 is the yeast homolog of ELAC2, we tested the
ability of ELAC2 to functionally complement deletion of
TRZ1 in yeast. YL03-47 was transformed with an array of
ELAC2 constructs (full length ELAC2, FLAG tagged
ELAC2, N-domain ELAC2, C-domain ELAC2, and four
full length ELAC2 variants found in prostate patients)
(Table 4). Transformants were plated onto FOA to select
against the TRZ1 expression plasmid and to determine if
any construct could complement trz1. As shown in Table
4, neither wild type nor prostate cancer-associated ELAC2
mutants could substitute for wild type TRZ1 function in
YL03-47. The human paralog of ELAC2, ELAC1, likewise
failed to rescue trz1 (Table 4).
We next incorporated three specific mutations into the
histidine motif region of TRZ1: (i) M535T, which
Induction of exogenous FLAG•Trz1p Figure 1
Induction of exogenous FLAG•Trz1p. A. Growth of YL09-02 
was initiated in raffinose complete medium. After overnight 
growth at 30°C, the culture was diluted with raffinose com-
plete medium to O.D. 0.2–2.3 at 600 nm, grown to O.D. 0.4, 
then induced in exponential growth phase with 2% galactose 
for varying periods of time before processing for Western 
blot. B. YPH499 and YL10-04 were grown as described 
above and induced with 2% galactose for 4 hours before har-
vesting for Western blot. Arrow indicates FLAG•Trz1p.
A.
B.BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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corresponds to the missense substitution A541T in ELAC2
that is associated with human prostate cancer; (ii)
H542ter, which corresponds to the frameshift 1641insG
associated with human prostate cancer; and (iii) G548R,
which corresponds to a ts mutant, G256R, that was iso-
lated in the homologous yeast gene PSO2 [16] (Figure 2)
(trz1 M535T, trz1 H542Ter, trz1 G548R; Table 4). Nota-
bly, in no case did the fusion of two copies of the FLAG
epitope to TRZ1 alleles influence results (Table 4). The
missense mutant TRZ1 allele (trz1 M535T) complements
trz1 as well as the wild type gene. However, neither trz1
G548R in which a conserved glycine in the histidine motif
is altered, nor the mutant TRZ1 truncated after His542 in
the same motif (trz1 H542Ter) could complement trz1 in
yeast.
Motif searches identified a putative P-loop (A/GxxxxGKS/
T) at amino acids 276–283 of human ELAC2 (AxxxxGKS).
This sequence element is located near the center of the N-
domain and is clearly conserved among the eukaryotic
orthologs. The corresponding sequence in Trz1p
(AxxxxGQT, residues 224–231) falls within the range of
variation for the structural P-loop recently explored by
Brakoulias et al [17]. In the homology between the N- and
C-domains of the protein, this candidate P-loop corre-
sponds to a strongly conserved element near the middle of
the C-domain (residues 693–700 of Trz1p), which also
has features reminiscent of the structural P-loop [17]. For
simplicity, we will refer to these as the first and second
putative P-loops. In so doing, however, we recognize that
they may be examples of some other conserved structural
element. We mutated the key residues in both putative P-
loops individually and tested the mutants' abilities to
complement trz1. The first putative P-loop is dispensable
for survival because mutants trz1 G229D and trz1 Q230A,
which should destroy its function if it is a P-loop [18,19]
(and are far outside the cross-species range of variation of
the sequence element if it is not a P-loop), can function-
ally substitute for the essential function of Trz1p. How-
ever, the second putative P-loop is required for yeast
Table 3: growth comparison on different sugar
Glucose Sucrose
RT 30°C 37°C RT 30°C 37°C
YPH499 +++++ ++++ +++++ ++++ +++++ +++++
YL09-01 +++++ ++++ +++++ ++++ +++++ +++++
YL10-01 +++++ +++ +++ ++ ++++ ++
YL10-02 +++++ +++ +++ ++ ++++ ++
YL10-03 +++++ ++++ +++++ ++++ +++++ +++++
YL03-47 +++++ ++++ +++++ ++++ +++++ +++++
Raffinose Galactose
RT 30°C 37°C RT 30°C 37°C
YPH499 +++ +++++ +++ ++ +++++ ++
YL09-01 +++ +++++ +++ ++ +++++ ++
YL10-01 ++ ++ - - -
YL10-02 ++ ++ - - -
YL10-03 +++ +++++ +++ ++ +++++ ++
YL03-47 +++ +++++ +++ ++ +++++ ++
SC-glucose: 3 days at RT, 2 days at 30 and 37°C.
SC-sucrose: 3 days at RT, 2 days at 30 and 37°C.
SC-raffinose: 3 days at RT, 2 days at 30 and 37°C.
SC-galactose: 4 days at RT, 2 days at 30 and 37°C.
+++++ fully grown spot with pink color
++++ fully grown spot with weak pink color
+++ fully grown spot with white color
++ clearly seen by eye
+ barely seen by eye
Yeasts were inoculated into 2 mls of SC-raffinose medium and grew overnight at 30°C. The resultant overnight cultures were diluted with SC-
raffinose medium to O.D. at 600 nm 0.2 and returned to growth at 30°C for another 2–4 hours to get to the exponential growth phase. Then the 
cultures were diluted to O.D. 600 nm 0.2. These freshly diluted cultures were serially diluted and spotted onto SC plate with different sugars 
added.BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
Page 6 of 16
(page number not for citation purposes)
survival because mutants here (trz1  G698D and trz1
D699A) cannot complement TRZ1  deletion. Sequence
analysis shows that TRZ1 may be the result of ancient tan-
dem duplication/fusion that produced a gene with
homologous amino and carboxyl halves. We therefore
tested whether either the N- or C- domain of TRZ1 alone
is capable of rescuing trz1. Neither half could rescue
(FLAG.TRZ1.C-term and FLAG.TRZ1.N-term), even when
fused to the complementary domain of ELAC2
(FLAG.TRZ1-ELAC2 and ELAC2-TRZ1) (Table 4).
Screen for and characterization of temperature sensitive 
(ts) TRZ1 mutants
We screened for ts mutants of Trz1p with PCR-based ran-
dom mutagenesis and bacterial mutator approaches; nei-
ther of these attempts identified ts mutants. To
circumvent technical difficulties, we used a targeted
approach instead. We designed degenerate oligos
targeting sequence encoding amino acids 535, 536, 537,
538, 541 and 548 in the Trz1p histidine motif (Figure 2).
These amino acids were selected for mutagenesis because,
with the exception of residue 548, they are less conserved
across species than the canonical residues of the histidine
motif; therefore, mutation may be less likely to com-
pletely inactivate protein function (Fig. 2). G548 was tar-
geted because, as mentioned before, a ts mutant had been
identified at the corresponding amino acid in S. cerevisiae
PSO2. We generated 6 mini-libraries, each of which tar-
gets one of these residues in YL03-47, and isolated the
clones that appeared at 30°C but that grew slowly or not
at all at 37°C. To confirm the ts phenotype plasmids from
these isolates were purified and used to transform naïve
YL03-47. The screen identified two ts mutants of Trz1p,
Y537L and L538K (Figure 3). We also found mutations at
position 535, 536, 537, 538, 541 and 548 that are lethal
at both 30°C and 37°C. Observation of lethal missense
substitutions at M535 is intrinsically interesting because it
is consistent with the idea that the corresponding residue
A541 of human ELAC2 is under some functional con-
straint. More than 60% of the lethal mutations were con-
centrated at G548, indicating that this residue is more
functionally constrained than the corresponding G256 of
S. cerevisiae PSO2 (data not shown).
We integrated TRZ1, trz1-537 (encodes Trz1p Y537L) and
trz1-538 (encodes Trz1p L538K) into the LEU2 locus in a
trz1 background to yield YL13-01, YL13-02, and YL13-03,
respectively. As shown in Figure 4, the ts mutants grew
more slowly on glucose medium than did the controls at
all temperatures tested. The inhibition of growth was
more obvious at higher temperature. Growth of the ts
mutants was further slowed on sucrose. When plated on
raffinose, ts mutants grow only at 30°C. YL13-02 and
YL13-03 are also petite mutants (i.e., ρ -) while YL13-01 is
not (Table 1). The ability of YL13-01 but not YL13-02 or
YL13-03 to grow on galactose can therefore be explained
in terms of the known inability of ρ - yeast to grow on
galactose [15]. Table 5 summarizes the doubling time for
each ts mutant at different temperatures in SC-Leu
medium containing glucose. At 30°C YL13-02 and YL13-
03 grow at about the same rate in liquid medium contain-
ing glucose as does YL13-01. However, at 37°C the ts
strains grow significantly more slowly in glucose (2–3
fold increase in doubling time) than does YL13-01.
We integrated the trz1-537 allele at the TRZ1 locus to yield
YL12-01. YL12-01 exhibits a slow-growth phenotype like
that of the LEU2 integrants (YL13-02 and YL13-03). YL12-
01 grows slower on glucose media compared with the iso-
genic wild type YPH499 at all temperatures tested and this
growth difference increases at 37°C (data not shown).
The trz1-537 integrants exhibit severe ts growth on sucrose
containing medium and they do not grow on raffinose
Table 4: Complementation of trz1
Constructs Complement ∆  trz1
ELAC2 No
ELAC2.FLAG No
FLAG. ELAC2.C-term No
ELAC2.N-term No
ELAC2 (S217L) No
ELAC2 (A541T) No
ELAC2 (R781H) No
ELAC2 (1641insG) No
ELAC1 No
TRZ1 WT Yes
FLAG.TRZ1 WT Yes
trz1 M535T Yes
FLAG.trz1 M535T Yes
trz1 H542Ter No
FLAG.trz1 H542Ter No
trz1 G548R No
FLAG.trz1 G648R No
trz1 G229D Yes
trz1 Q230A Yes
trz1 G698D No
trz1 D699A No
FLAG.TRZ1. C-term No
FLAG.TRZ1. N-term No
FLAG.TRZ1- ELAC2 No
ELAC2-TRZ1 No
The chimeric proteins are made by fusion of either the ELAC2 N-
domain with TRZ1 C-domain or the reverse. Trz1p N-domain ends 
at a.a. 463 and the C-domain starts at a.a. 465. The ELAC2 N-domain 
ends at a.a. 481 and the C-domain starts at a.a. 481.
The shuffle experiment is done in strain YL03-47 according to 
protocols described in [32]. The constructs are TRP -marked CEN 
vectors.BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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Protein multiple sequence alignment across the core histidine motif of selected ELAC/ tRNase Z family members Figure 2
Protein multiple sequence alignment across the core histidine motif of selected ELAC/ tRNase Z family members. The ELAC/
tRNase Z family members were selected from Saccharomyces cerevisiae (Sce), Schizosaccharomyces pombe (Spo), Arabidopsis thal-
iana (Ath), Drosophila melanogaster (Dme), Homo sapiens (Has), Escherichia coli (Eco) and Methanothermobacter thermautotrophi-
cum (Mth). The boxed residues in the S. cerevisiae sequence are the amino acids that we mutagenized in our effort to create a 
ts mutant. 1, S. cerevisiae M535 corresponds to human A541. 2, Y537L is ts. 3, L538K is ts. 4, H542 corresponds to human 
H548, the position of a prostate cancer associated frameshift. 5, G548 corresponds to G256 of S. cerevisiae PSO2; although 
PSO2 G256R is a ts mutant [16], TRZ1 G548R is lethal. * denotes identical amino acid, and : /. indicates homologous conserva-
tion across species.
ELAC/ RNase Z family members. 
Sce TRZ1 gi|6322932  466 - - V E I I T L G T G S A L P S K Y R NVVS  T  L  V
Spo gi|1177343 498 --IQ IC T L G T  G S  A M P S L Y R N V S  S T Y V
Ath gi|6850339  485 - - M E I V I  L G T G S S Q P S K Y R N V S A I  F I
Dme JHI-1 gi|42559651  455 - - P K I  I F L G T G S C I P N K T R N V S S I L I
Hsa ELAC2 gi|10880933  481 - - P E I I F L G T G S A I P M K I R N V S A T L V
Hsa ELAC1 gi|8922122 1 M S M D V T  F L G T  GAAYP  S  P  T  R  GAS  AVVL  
Eco elaC gi|1381661  1 - - M E L I F L G T S A G V P T R T R N V T A I  L L 
Mth gi|2622965  1 -  M M E V T F L G T S S A V P S K N R N H T S I A L 
. : ***. : * *. : :
Sce TRZ1 gi|6322932 490 K V P  F T D A - - - DGNT   I  N   R   N   I  ML   DAGE   N
Spo gi|1177343 522 R I P VDKKC  ME  DS  AI   S  M   K  N  I   L  L  DC  GE  G
Ath gi|6850339 509 D L  F S R -----------G S LLLDCGE  G
Dme JHI-1 gi|42559651 479 R T A I D - ----------A Y V L L D C G E  G
Hsa ELAC2 gi|10880933 505 N I S P D -----------T S L L L D C  G E  G
Hsa ELAC1 gi|8922122 27 R C E ------------G E C W L F D C G E  G
Eco elaC gi|1381661 25 N L  Q H P  --------T Q S G L W L F D C G E  G
Mth gi|2622965 26 R I P - - - - - - - - - - - - G E I F L F D C G E  G
::* .* * .
12 3
Sce TRZ1 gi|6322932  513 T L G T I H R M F S Q L A V K S I F Q D L K M I Y L 
Spo gi|1177343 548 T L G R  L S R QYG-   DNL  K  Y  E  I   A  S  L  R  W I   YI  
Ath gi|6850339  524 T L G Q L K R R Y G L D G A D E A V R K L R C I  W I 
Dme JHI-1 gi|42559651 494 T YGQI   VR  L  YGHE  KGQ  L  I   L  R  QL  QAI   YV
Hsa ELAC2 gi|10880933 520 T F G Q L  C R HYGD-   QVD  R  V  L  G  T  L  AAVF  V
Hsa ELAC1 gi|8922122  41 T Q T Q L M K S Q - -----L K A G R IT K IF I
Eco elaC gi|1381661 43 T QHQL   L   HT   A-  -  -  -  -  -  F   N   P   G   KL   DKI  F   I  
Mth gi|2622965 40 T Q R Q M A L  A G - - - - --IS P M K V T  R IF I
* : : :::
45
Sce TRZ1 gi|6322932 539 S H L  HADHHL   GI  I  S   VL   N   E   W   Y   KYN
Spo gi|1177343 573 S H M HADHHAGVI  GVL   K   A   W   T   -  -  -  
Ath gi|6850339 550 S H I HADHHT  GL  AR  I   L  A  L  R  S  KL  L  
Dme JHI-1 gi|42559651 520 S H L  HADHHI   GL  I   GL  L  R  E  R  R  -   -   -  
Hsa ELAC2 gi|10880933 545 S H L  HADHHT  GL  P  S  I   L  L  Q  R  E  R  AL  
Hsa ELAC1 gi|8922122 61 T H L  HGDHF  F  GL  P  GL  L  C  T  I   S  L  QS  
Eco elaC gi|1381661 63 S H L  HGDHL  F  GL  P  GL  L  C  S  R  S  MS  G
Mth gi|2622965 60 T H L  HGDHI  L   GI  P   GMI  Q   S   M   G   F   R   G
:* :* .* * * : ::BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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and galactose containing medium (data not shown). The
doubling time of these mutants in glucose-supplemented
liquid medium is in agreement with results from the plate
assay (Table 5). To verify that the growth phenotype and
sugar sensitivity observed with trz1-537 integrants do not
result from a cloning artifact, we did the following.
YPH499 and YL12-01 were transformed with empty vec-
tor (p416) or p416/TRZ1  and plated onto SC-Ura
containing glucose. Once grown, colonies were replica-
plated onto SC-Ura supplemented with glucose, sucrose,
raffinose or galactose. Providing a wild type TRZ1 on a
CEN vector restored the growth of YL12-01 to the level of
YPH499 on all media tested (Figure 5). YL12-01 trans-
formed with an empty vector grew more slowly than
YPH499 on all media tested, with the decrease in growth
rate in the order of glucose, sucrose, raffinose and galac-
tose media, in agreement with the previous plate assay. In
addition, we checked the ρ  status for these transformants.
Providing a copy of wild type TRZ1  on a CEN vector
(YL12-02) converted YL12-01 from ρ - to ρ + (Table 1), indi-
cating that the petite phenotype of YL12-01 may not be
due to the loss of mitochondrial DNA. Instead, it may
result from the interference of important mitochondrial
functions, suggesting that Trz1p also plays a role inside
mitochondria. However, normal growth on a non-fer-
mentable carbon source was not restored in diploid
strains derived from crosses between ts mutant strains and
a haploid ρ 0 tester strain (Table 1 and data not shown).
Given the fact that the tester strain should have a wild type
copy of TRZ1 and ts mutant haploid strains should have
mitochondrial DNA, we speculate that ts alleles of TRZ1
may have pleiotropic effects on certain important activi-
Temperature sensitive growth of yeast expressing alleles trz1-537 and trz1-538 Figure 3
Temperature sensitive growth of yeast expressing alleles trz1-537 and trz1-538. Isolates of yeast expressing trz1-537 (A1, B1, 
C1, D1) or trz1-538 (B3, C3, D3, E3) (YL03-47 with ts alleles on a LEU2 plasmid) were streaked onto SC-LEU plates and incu-
bated at RT or 37°C. YPH499 and YL03-47 were used as controls.
RT               37°C YL03-47
A1
T
B1 C1
D1
TRZ1
W
YPH499
Trz1-537
YL03-47
B3
T
C3 D3
E3
TRZ1
W
YPH499
Trz1-538BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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Growth at different temperatures of yeast expressing TRZ1, trz1-537 or trz1-538 alleles on media with various carbon sources  added Figure 4
Growth at different temperatures of yeast expressing TRZ1, trz1-537 or trz1-538 alleles on media with various carbon sources 
added. Yeast bearing TRZ1 alleles integrated at the LEU2 locus [YL13-01 (WT), YL13-02 (tr1-537) and YL13-03 (trz1-538)] 
were serially diluted and spotted onto SC-LEU with different sugars added. Plates were incubated at RT (upper), 30°C (middle) 
and 37°C (lower).
Glucose    Sucrose           Raffinose        Galactose 
RT
30°C
37°C
YL13-01
YL13-02
YL13-02
YL13-03
YL13-03BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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ties in mitochondria. The effect on some of these activities
may be dominant, and mating with a wild type haploid
strain lacking mitochondrial DNA may not fully restore
the mitochondrial functions.
To determine if the trz1-537 allele causes any cell cycle
arrest phenotype, we analyzed YL12-01, with YPH499 as
control, by FACS; both strains were grown at RT or 37°C
for this study. Allele trz1-537 caused a 1 hour delay in cells
entering 2N (M phase) at 37°C. When yeast reached sta-
tionary phase, YL12-01 had more cells in 2N (M phase)
than YPH499 grown under the same conditions (data not
shown). When viewed under a microscope the trz1-537
integrants were observed to aggregate when grown at
37°C while parental YPH499 cells did not. With YL12-01
we also observed enlarged cells and cells with elongated
buds; the percentage of these abnormally shaped cells
increased with the length of time that the cells were grown
at 37°C (data not shown). Therefore, trz1-537 allele does
not cause any cell cycle arrest phenotype and the abnor-
mal shape we observed is most likely the result of cell
death in yeast.
High copy suppressor screen
During the characterization of YL12-01, we identified a
window of two days wherein it would be possible to
screen for high copy suppressors of trz1-537. As shown in
Figure 6, at 30°C, the appearance of YL12-01/p416Gal1
transformants takes 4 days on SC-URA. However, colonies
appear after only 2 days when the same strain is trans-
formed with p416/TRZ1 (YL12-02). YPH499 transformed
with vector or TRZ1 resulted in observable colonies after
2 days of incubation at 30°C on SC-URA. Therefore, we
screened for high copy suppressors of trz1-537 by using
yeast genomic fragments to transform YL12-01 and select-
ing transformants that had grown out in 2-3 days. We
screened approximately 34,000 genomic fragments and
isolated 4 suppressor clones. Two of the four clones
yielded an identical sequence from a 8057 bp genomic
region on chromosome 12 (253,621-261,678) that con-
tains four genes (ERG3, YLR057w, SHM2 and REX2). One
of the remaining clones includes a 2594-bp genomic
sequence from chromosome 11 that contains the full-
length coding region of TRZ1 plus 25 bp of 5'UTR and 53
bp of 3'UTR. The 4th clone contains chromosome 12
sequences at one end (from 794,633 down) and Ty3 LTR
at the other. This last clone was not pursued further.
We cloned each of the four genes on the 8057 bp region
of chromosome 12 and inserted these independently into
CEN and 2 µ expression vectors containing the CYC1
promoter. We tested each gene for an ability to rescue the
ts phenotype of trz1-537 yeast. Only REX2 rescued the ts
phenotype and rescue was observed with both CEN and 2
µ vectors. REX2 encodes a RNA 3' processing enzyme that
localizes to mitochondria [20,21].
Discussion
In this paper, we report investigation of TRZ1, the yeast
homolog of ELAC2. Altered expression of TRZ1 in yeast
does not cause any altered growth phenotype. Conserva-
tion of the histidine motif and the C-domain putative P-
loop is important for the essential function of Trz1p in
yeast. Trz1p (Y537L), a ts mutant, exhibits a slow growth
phenotype on a variety of yeast media. Additional copies
of  REX2  rescue the slow growth phenotype associated
with Trz1p (Y537L), providing genetic confirmation that
the product of TRZ1 plays a role in RNA processing.
1. Altered expression of TRZ1 is not detrimental to yeast 
growth
Although  TRZ1  is an essential gene, yeast can tolerate
altered expression of TRZ1. We down-regulated TRZ1
message by deleting the endogenous gene and expressing
Table 5: Doubling time of ts allele integrants
Strain LEU2 locus RT 37°C
YL13-01 TRZ1 WT 5.54 ± 0.26 1.44 ± 0.04
YL13-02 trz1-537 6.87 ± 0.85 2.88 ± 0.01
YL13-03 trz1-538 6.31 ± 1.03 4.87 ± 1.15
Strain TRZ1 locus RT 37°C
YPH499 WT 3.17 1.85
YL12-01 trz1-537 4.75 ± 0.06 3.67 ± 0.02
Yeasts were inoculated into 2 mls of SC-glucose medium and grew at 30°C overnight. The overnight cultures were diluted with SC-glucose medium 
to O.D. at 600 nm 0.1 and returned to 30°C with shaking. The O.D. 600 nm reading was monitored throughout the day until it was more 1. 
Doubling time was calculated as described in table 2.BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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Wild type TRZ1 restores growth at 37°C of YL12-01 on media supplemented with different sugars Figure 5
Wild type TRZ1 restores growth at 37°C of YL12-01 on media supplemented with different sugars. YPH499 (A) and YL12-01 
(B) were transformed with either an empty vector (upper plates) or a vector bearing the wild type TRZ1 gene (lower plates). 
Transformants were replica-plated onto SC-URA containing different sugars and incubated at 37°C for 2 days. Wild type TRZ1 
restores the growth of ts strain YL12-01 on all carbon sources.
               Glucose     Sucrose          Raffinose     Galactose 
YPH499 transformed with empty vector p416 (upper tier) or p416/TRZ1 (lower 
tier)
YL12-01 transformed with empty vector p416 (upper tier) or p416/TRZ1 (lower 
tier)BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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TRZ1 from a Gal1 promoter on a CEN plasmid. We could
not detect any apparent growth defect when TRZ1 expres-
sion was suppressed on glucose-containing medium. We
also over-expressed exogenous TRZ1 message and protein
from a Gal1 promoter on backgrounds of either an intact
or deleted endogenous TRZ1 locus. In neither of these
backgrounds does over-expression of TRZ1 cause any sig-
nificant alteration of yeast doubling time. We also
attempted to decrease TRZ1 mRNA by integration of a
thermal labile cassette (Degron approach; data not
shown) or by insertion of a Gal1 promoter just upstream
of the endogenous TRZ1  coding sequence. In these
attempts, however, we did not obtain any integrants that
were not petite mutants.
In conclusion, under or overexpression of TRZ1 does not
grossly affect growth or cell cycle; however, the tendency
for alteration in this gene to cause a petite phenotype con-
founds our ability to detect small perturbations.
2. ELAC2 cannot substitute for TRZ1 function and the C-
domain putative P-loop is important for TRZ1 essential 
function
Human ELAC2 cannot rescue TRZ1 deletion in yeast. We
observed this with both full-length ELAC2 and with
TRZ1/ELAC2 and ELAC2/TRZ1 fusions. The same lack of
complementation was observed with ELAC1, the paralog
of ELAC2. These results could be explained if ELAC1 and
ELAC2 have overlapping but not totally redundant func-
Growth difference exploited for suppressor screen Figure 6
Growth difference exploited for suppressor screen. YPH499 and YL12-01 were transformed with either an empty vector 
(p416) or with p416/TRZ1 expressing a wild type TRZ1 gene. Transformants were plated onto SC-URA and incubated at 30°C 
for 3 days.
YPH499                   YL12-01
p416
p416/TRZ1BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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tions. TRZ1 is more similar to ELAC2 than to ELAC1, but
Trz1p may accomplish functions in yeast performed by
both ELAC1 and ELAC2 in humans. Therefore, substitut-
ing TRZ1 with either one of these genes may not replace
all of the essential functions of Trz1p in yeast. It would be
interesting to see whether supplying both human ELAC1
and ELAC2 could rescue TRZ1 deletion in yeast.
A motif search found two putative nucleotide-binding
motifs (P-loops) in TRZ1  and ELAC2, one in the N-
domain and one in the C-domain of each gene [2]. The
finding that yeast tolerates mutation of the N-domain but
not the C-domain P-loop of TRZ1 suggests the putative C-
domain nucleotide-binding motif plays an important role
in Trz1p function. The fact that the C-domains of TRZ1
and ELAC2 contain the most conserved sequence across
other organisms also supports the notion that the vital
functions of TRZ1 require that this sequence element is
intact. However, the N-domain of Trz1p is also necessary
for function because expression of an N-terminally
deleted  TRZ1  does not rescue trz1  yeast, nor did the
expression of the fusion protein between the N-domain of
human ELAC2 and the C-domain of yeast TRZ1. This
observation is consistent with the results from Nashim-
oto's lab [9]. Their data suggest that the N-terminal half of
ELAC2 (human tRNase ZL), to which family yeast TRZ1
also belongs, is responsible for substrate specificity and
confers RNase 65 activity that is not present in ELAC1
(human tRNase ZS). And the activities of tRNase Z and
RNase 65 toward a set of substrates between human
ELAC2 and yeast TRZ1 are different, suggesting the N-
domain of tRNase ZLs is essential for certain functions in
the cell and they may not functionally equivalent among
different species [9].
3. Potential role of TRZ1 in rRNA biogenesis, mRNA 
splicing and mitochondrion maintenance in addition to its 
role in tRNA processing
The majority of the RNA in growing yeast is noncoding
[13] including rRNA, tRNA, snRNA, snoRNA as well as the
RNA components of RNase P and RNase MRP. These
RNAs are involved in processes that are vital to cell sur-
vival. The biogenesis of rRNA is a complicated process
that involves a large number of proteins and RNAs that
catalyze or modulate transcription, translocation, and var-
ious processing reactions, including exonucleolytic and
endonucleolytic cleavages, ligations, terminal additions
(5S), and nucleoside modifications. The details of yeast
rRNA processing and some of the complexes involved
have been described [13,14,22,23].
REX proteins (RNA exonucleases) belong to a family of
well-conserved RNA 3' →  5' exonucleases [24]. Rex1p is
required for 5S and tRNA-Arg3 maturation. Deletion of
Rex2p results in a defect in the processing of the U4
snRNA that is involved in mRNA splicing. Rex3p is
required for the maturation of MRP RNA, an important
endonucleolytic complex involved in processing both
rRNA and tRNA. Rex1p and Rex2p have been shown to be
involved in the final maturation of 5.8S rRNA. Rex1p,
Rex2p and Rex3p are also involved in the maturation of
U5 snRNA and the RNA subunit of RNase P, the RNase
that is involved in both tRNA 5' and rRNA maturation. In
addition to participating in tRNA and rRNA processing,
Rex2p has been implicated in spliceosome assembly by
association with the snRNP U2 component PRP11, in
DNA repair by association with Rad50p, and in cytoskele-
ton reorganization by association with the actin cortical
patch component Cof1p [25]. Rex2p localizes to the mito-
chondria and interacts genetically with YME1 and YME2,
components of the inner mitochondrial membrane that
participate in mitochondrion organization and biogenesis
[20,21]. In summary, the REX proteins function in both
RNA maturation and mitochondrial maintenance. The
finding that REX2 rescues the slow growth phenotype of
yeast expressing Trz1p (Y537L), suggests that TRZ1 may
also participate in those same processes. Further support
for this hypothesis comes from the finding that TRZ1
exists in a complex with NUC1 [26,27], an RNase and
DNA endo/exonuclease that localizes to the mitochondria
and is involved in mitochondrial DNA recombination. In
addition, we observed that supplying an extra copy of wild
type TRZ1 on a CEN plasmid alters YL12-01, converting
the ts mutant Trz1p (Y537L) from ρ - to ρ + (Table 1). The
mitochondrial localization of Trz1p [26] together with
the suppression of the Trz1p (Y537L) phenotype by REX2
and the effect of expression of wt TRZ1  on the petite
mutant status of YL12-01 suggest that Trz1p may partici-
pate in the activities of mitochondria.
The human homolog of TRZ1, ELAC2, was identified as a
candidate prostate cancer susceptibility gene [2]. Schiffer
et al. [5] purified a nuclear tRNase Z from wheat germ and
found two homologs of tRNase Z in A. thaliana, NUZ
(nuclear RNase Z) and CPZ (chloroplast RNase Z). Both
Arabidopsis homologs have tRNase Z activity in vitro. These
authors also showed that NUZ is a homolog of ELAC1
and represents a family of proteins that is conserved from
bacteria to humans. Subsequently, Takaku et al. showed
that human ELAC2, its paralog ELAC1, and the yeast
homolog TRZ1 have tRNase Z activity in vitro [3]. The
finding in this study that extra copies of REX2 rescue a ts
allele of TRZ1 confirms a role for Trz1p in the processing
of RNA, placing TRZ1 in particular in rRNA and tRNA
maturation pathways. This is consistent with previous
results. First, rRNA biogenesis involves processes both in
the nucleolus and cytoplasm, and TRZ1 protein localizes
to both of these cellular compartments [28]. Second,
many proteins and some complexes, for example, MRP,
RNase P and the RNA polymerase III complex, participateBMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
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both in tRNA and rRNA processing and synthesis. There-
fore it is possible that TRZ1 participates in both tRNA and
rRNA processing. Third, using a tet-promoter TRZ1 allele
and a custom DNA oligo array for noncoding RNA bio-
genesis, Peng et al. demonstrated that TRZ1 has an unde-
fined role in the processing of 35S rRNA [29]. The high-
copy suppressor result could also be explained more
straightforwardly if we assume that Trz1p (Y357L) has
diminished or abolished tRNase Z activity, which could
result in low level of mature tRNAs, and Rex2p could
remove the 3' trailers from pre-tRNAs exonucleolytically,
that could result in restored mature tRNA levels.
Since ELAC2 cannot functionally complement TRZ1 dele-
tion, we cannot directly test in yeast the functional effect
of the human ELAC2 missense substitution A541T, which
appears to confer modest risk of prostate cancer [30].
Although this variant does not seem to affect the tRNase Z
activity of human ELAC2 in vitro [3], we did find that
some missense substitutions at the corresponding yeast
residue, M535, are lethal, demonstrating that this posi-
tion is under functional constraint. Recent demonstra-
tions that hoe-1, the C. elegans homolog of ELAC2, plays a
role in germline proliferation [31], and human ELAC2
maybe involved in cell cycle regulation [4], may help bet-
ter illuminate the contribution of ELAC2 to the etiology of
human prostate cancer.
Conclusion
We have undertaken a genetic study of yeast TRZ1 gene,
the homolog of prostate cancer susceptibility gene ELAC2.
Our data suggest that the absolute level of TRZ1 transcript
is not important for the fitness of yeast, the vital functions
of TRZ1 require an intact C-terminal P-loop and some
conserved residues in Histidine motif. More importantly,
our high copy suppressor screen suggests that TRZ1  is
involved in RNA processing, especially rRNA processing
and mitochondrial biogenesis.
Methods
Strains and Reagents
The strains used in this study are listed in Table 1. The
petite status of each strain, determined by growth on a
non-fermentable carbon source, is listed in Table 1.
YPH499, YPH500, and YPH501 were purchased from
Strategene (La Jolla, CA). Genetic manipulations, yeast
growth conditions and preparation of yeast media and
plates were as described [32]. Yeast transformation and
gene disruption were carried out using lithium acetate
[32]. Cloning and manipulation of yeast plasmids were
done in bacterial strain DH5α . Yeast medium was pur-
chased from Qbiogene (Carlsbad, CA). 5'-Fluoroorotic
acid (5'-FOA), used at a concentration of 0.1%, was pur-
chased from Toronto Research Chemicals, Inc. (Ontario,
Canada).
Plasmid and strain construction
A 3.7 kb fragment containing TRZ1 coding sequence and
intergenic regions was amplified from yeast genomic DNA
(primer sequences available upon request) and cloned
into pBluescript-KS (BSKS/TRZ1). To express epitope-
tagged protein, TRZ1 N- and C-termini were re-engineered
using PCR. We generated BSSK TRZ1•FLAG (2 copies of a
FLAG epitope fused to the C-terminus), BSSK/TRZ1•V5 (1
copy of a V5 epitope fused to the C-terminus), BSSK/
TRZ1•3XHA or BSSK/TRZ1•3Xmyc (3 copies of HA or
Myc epitopes fused to the C-terminus, respectively) and
BSSK/FLAG•TRZ1 (2 copies of a FLAG epitope fused to
the N-terminus). Site-directed mutagenesis was per-
formed with QuikChange Site-Directed Mutagenesis kit
from Stratagene (La Jolla, CA) following their protocols.
YL03-47 is a trz1 haploid strain in which the genomic trz1
is complemented by high-copy episomal TRZ1. To con-
struct this strain, first a TRZ1/trz1 heterozygote, was gen-
erated using a DNA fragment
(TRZ1•hisG•URA3•hisG•TRZ1) that contained in succes-
sion: the TRZ1 promoter region; the 5' 37 codons of TRZ1;
URA3  flanked by hisG  cassettes; the 3' 123 codons of
TRZ1; and 108 bp of sequence 3' of the TRZ1 stop codon.
YPH501 was transformed with this fragment, and TRZ1/
trz1  heterozygotes were selected as uracil prototrophs.
Next, one such TRZ1/trz1 heterozygote was plated onto
FOA to select a URA3-deficient derivitive of the TRZ1/trz1
heterozygote. This TRZ1/trz1 uracil auxotroph was then
transformed with a 2 µ URA3 TRZ1 expression plasmid
(pRS426/TRZ1). Finally, to obtain YL03-47, tetrads from
the resulting transformants were dissected, and URA+ col-
onies were screened by PCR for the presence of hisG
sequence at the endogenous TRZ1 locus.
YL12-01, in which the chromosomal TRZ1  is replaced
with trz1-537 allele, is constructed from YPH499 follow-
ing a two-step gene replacement strategy. DNA fragment
encoding the ts mutant trz1-537 allele was cloned into an
URA3-marked integrating vector (p406/trz1-537). The
resulting plasmid was linearized with Bgl II and trans-
formed into YPH499 to integrate into TRZ1 chromosomal
locus. Uracil prototrophs were selected from the transfor-
mation and plated on FOA to select cells that had under-
gone excision of the plasmid. The replacement of wild
type TRZ1  with the ts mutant trz1-537  allele was con-
firmed with sequencing.
YL13-01, YL13-02 and YL13-03, in which the chromo-
somal TRZ1 is deleted and a wild type TRZ1 or a trz1-537
allele or a trz1-538 allele is integrated at the LEU2 locus,
were generated as follows. DNA fragments encoding
TRZ1, or the ts mutant alleles trz1-537 or trz1-538 were
cloned into an integrating LEU2-marked vector (p405/
TRZ1). The resultant plasmids were linearized with BstXI,BMC Molecular Biology 2005, 6:12 http://www.biomedcentral.com/1471-2199/6/12
Page 15 of 16
(page number not for citation purposes)
and YL03-47 was transformed with the fragments for inte-
gration into the leu2-∆  1 locus. Leucine prototrophs were
selected from the transformation and plated on FOA to
select cells that had lost pRS426/TRZ1. The identity of the
integrated alleles was confirmed by PCR and sequencing.
Western blot
Yeast cells were grown as indicated in the text. Usually,
about 1.5 ml yeast culture with an A600 of about 0.6 was
centrifuged and the pellet resuspended in 150 µL boiling
buffer (50 mM Tris pH8.0, 0.1% Bromophenol blue, 2%
SDS, 10% glycerol and fresh 0.1 M DTT). The yeast sus-
pension was heated to 95°C for 20 minutes followed by
vortexing and centrifugation at 14000 rpm for 1 minute.
The resulting cellular extract was loaded onto a SDS-PAGE
gel. Electrophoresis, transfer and Western blot were car-
ried out using Invitrogen's XCell SureLock system follow-
ing their protocol. Anti-myc and anti-V5 antibodies were
purchased from Invitrogen (Calsbad, CA) and used at
1:2000 dilution. Anti-FLAG antibody was purchased from
Sigma (St. Louis, MO) and used at 1:400 dilution.
Temperature-sensitive (ts) mutant screen
To prepare for a screen for TRZ1 mutations that rendered
yeast growth temperature-sensitive, the codons of specific
TRZ1 amino acids were mutagenized. We targeted amino
acids 535, 536, 537, 538, and 541 for ts screening. To
mutagenize amino acid 535, a pair of oligos with degen-
erate nucleotides encoding residue 535 were synthesized.
The primer sequences were as following: 079c.535.F (5'-
CAG GAT TTG AAA NNN ATA TAT CTG AGT CAC-3'),
079c.535.R (5'-ACT CAG ATA TAT NNN TTT CAA ATC
CTG AAA TAT TG-3'), 079c.NdeI (5'-GAT TAT GAT TGT
GCT GAG CTT GGC-3'), 079c.BglII (5'-TTC TTC ACG
GCA TCC TCC AGT AGC-3'). Two fragments were
generated by primary PCR with wild type TRZ1 coding
sequence as template and 079c.NdeI/079c.535.R and
079c.535.F/079c.BglII as primers. About 100 ng of each of
the resulting fragments were mixed and used as templates
for secondary PCR using 079c.NdeI/079c.BglII as primer.
The resulting PCR products were purified by Qiagen PCR
column, mixed with p415/TRZ1 (∆  NdeI-NcoI) that lacks
TRZ1 sequence between Nde I and NcoI sites, and the
mixture used to transform competent YL03-47. Trans-
formants were plated onto SC-LEU. For other targeted
amino acids, PCR-generated mini-libraries were made by
following a similar strategy to that outlined above. About
500 colonies were screened for each targeted amino acid.
After two days' growth on SC-Leu media at 30°C, colonies
were replica-plated onto two SC-Leu+FOA plates, one of
which was incubated at 30°C, while the other was incu-
bated at 37°C. After 24 hours colonies that grew at 30°C
but failed to grow at 37°C were isolated from the original
SC-LEU plate. The LEU2 marked plasmids were isolated,
sequenced, and used to retransform YL03-47. Transform-
ants were plated on FOA to select yeast that had lost p426/
TRZ1 and streaked onto SC-LEU+FOA plates to confirm
the temperature sensitive phenotype.
High copy suppressor screen
A 2 µ URA3-marked yeast genomic library (gift from Mike
Forte and Beth Lachlyd, Vollum Institute, Portland, OR)
was used to transform YL12-01. Transformants were
plated onto SC-URA and after four days' incubation at
30°C, colonies were picked. About 90 colonies were
picked out of a total of 70,000 colonies screened. The
library plasmids were isolated and used to retransform
YL12-01. The suppressor phenotype was confirmed by
comparing the growth of YL12-01 transformed with each
library plasmid with that of YL12-01 transformed with
p416/Gal1 and p416/TRZ1. The sequence of the high
copy suppressors was determined.
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TRZ1: tRNase Z 1
tRNase Z: transfer RNA (tRNA) 3' processing
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snRNA: small nuclear RNA
snoRNA: small nucleolar RNA
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